Media
Press releases
Quotient Limited Announces receipt of Note Holders Consents to Indenture Amendments That Extend Maturity, Defer Principal Payments on 12% Senior Secured Notes
• Notes holders unanimously consent to amendments
• Company’s near-term cash obligations reduced by approximately $60 million
• Transaction extends liquidity runway through commercial launch and provides resources for further MosaiQ investment
Quotient Limited Announces Appointment of Chief Financial Officer
JERSEY, Channel Islands, October 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Company’s Chief Financial Officer (CFO). Mr. Kiboro will assume the responsibilities of CFO on November 1st, 2021, replacing Mr.…
Quotient Limited Announces Appointment of Chief Commercial Officer
JERSEY, Channel Islands, October 5, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced Mohammad El Khoury as the Company’s Chief Commercial Officer. In this role, Mr. El Khoury will oversee all commercial activities for the company as it…
Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
JERSEY, Channel Islands, October 4, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Dr. Christine Ginocchio as Chief Scientific & Medical Officer (CSMO).
Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray
Quotient Limited Announces Christian Albrich as Chief People Officer
JERSEY, Channel Islands, September 1, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that Christian Albrich has been appointed as Chief People Officer of the Company and…
Quotient Limited Announces Departure of Chief Commercial Officer, Jeremy Stackawitz
JERSEY, Channel Islands, 11 August 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Jeremy Stackawitz has notified the Company that he is resigning from his position as Chief Commercial Officer.
Quotient Limited Provides First Quarter Fiscal 2022 Results and Business Update
Quotient Limited Announces Equity Awards
JERSEY, Channel Islands, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the grant of equity awards to Dr. Michael Hausmann, who has been appointed as the Chief Technology Officer of the Company effective August…
Quotient Limited to Report First Quarter Fiscal Year 2022 Financial Results and Host Conference Call
JERSEY, Channel Islands, July 29, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2021 will be released before market open on Thursday, August 5, 2021.